Companies: 10,795·Total market cap: $144.5T
CBD Life Sciences Inc.

CBD Life Sciences Inc.

CBDLOTCHealthcare● Active
$0.00
$-0.00(-16.67%)
Market Cap$469243
P/E Ratio—
52W High$0.001
52W Low$0.0001
Overview

CBD Life Sciences Inc.（CBDL）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

cbdl · 股价预测 · 2 位分析师（近3月）· FMP · 更新于 2021年1月29日

分析师评级与共识

基于过去 3 个月内 2 位华尔街分析师

SellBuy

Buy

2 位分析师

共识

评级分布

Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
合计: 2 · 买入占比: 50.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $0.00

CBD Life Sciences Inc.（CBDL）的分析师共识为 Buy，基于过去 3 个月内 2 位华尔街分析师的评级。CBDL 的 12 个月平均目标价为 $0.00，相对当前价 $0.00 代表 +0.0% 的潜在上行空间。

短期股价预测

📅
财报窗口期

在 ±3 天财报窗口期内暂停短期预测，以避免不可靠信号。

长期股价预测

⚠️ 在满 252 个交易日历史（IPO/上市时间较短）前不展示长期预测；短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Elevated Volatility — Earnings Window Active (±3 days)· Technical signals still shown. M3 predictions paused.

Market Sentiment

NEUTRAL

Based on 14 technical indicators

0%57%43%
0Buy
8Neutral
6Sell
RSI (14)39.1Neutral
MACDNEUTRAL

Refreshes daily from EOD close

Moving Averages · CBDL · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.00SELL
MA 10$0.00SELL
MA 20$0.00SELL
MA 50$0.00NEUTRAL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $CBDL · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.00SELL
EMA 10$0.00SELL
EMA 20$0.00SELL
EMA 50$0.00NEUTRAL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $CBDL · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Cantor Fitzgerald2021-01-29
Maintains
Neutral→Neutral
Benchmark2020-09-09
Maintains
Speculative Buy→Speculative Buy
Cantor Fitzgerald2020-08-13
Maintains
Neutral→Neutral
Cantor Fitzgerald2020-05-18
Maintains
Neutral→Neutral
Benchmark2019-12-19
Maintains
Speculative Buy→Speculative Buy

Wall Street analysts have recently issued updated ratings on CBD Life Sciences Inc. (CBDL) stock. Of the recent 5 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover CBDL.

分析师推荐趋势

Buy ratings1 → 0↓ 1
Hold ratings0 → 1↑ +1
Sell ratings0 → 0

CBDL analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

—

Revenue Next Year

—

EPS This Year

—

EPS Next Year

—

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CBDL EPS of $— for the current fiscal year, based on estimates from 0 analysts. The CBDL revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

CBDL 股价预测由两类独立数据源支撑：来自 2 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CBDL 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。

CBD Life Sciences Inc. 在 OTC 上市，代码 CBDL。CBDL 在 2027 年的整体展望偏积极，在覆盖分析师中约 50% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

CBDL 预测 · 8 个问题

根据 2 位华尔街分析师，CBDL 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $0.00，隐含约 +0.0% 的上行空间。

CBDL 目标价CBDL 分析师目标价CBDL 12个月目标价目标价 CBDL

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.